Advertisement

Headache in Adolescents

  • Irene Patniyot
    Correspondence
    Corresponding author. Texas Children’s Hospital, West Campus, 18200 Katy Freeway, Suite 360, Houston, TX 77094.
    Affiliations
    Section of Neurology and Developmental Neuroscience, Department of Pediatrics, Texas Children’s Hospital Pediatric Headache Clinic, Baylor College of Medicine, Houston, TX, USA
    Search for articles by this author
  • Author Footnotes
    1 Present address: 9645 Grove Circle North Suite 100, Maple Grove, MN 55369.
    William Qubty
    Footnotes
    1 Present address: 9645 Grove Circle North Suite 100, Maple Grove, MN 55369.
    Affiliations
    Division of Child Neurology, Minneapolis Clinic of Neurology, Minneapolis, MN, USA
    Search for articles by this author
  • Author Footnotes
    1 Present address: 9645 Grove Circle North Suite 100, Maple Grove, MN 55369.
Published:October 29, 2022DOI:https://doi.org/10.1016/j.ncl.2022.08.001

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Neurologic Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Burch R.C.
        • Buse D.C.
        • Lipton R.B.
        Migraine: Epidemiology, Burden, and Comorbidity.
        Neurol Clin. 2019; 37: 631-649
        • Lewis D.W.
        Pediatric Migraine.
        Neurol Clin. 2009; 27: 481-501
        • Vos T.
        • Abajobir A.A.
        • Abbafati C.
        • et al.
        Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016.
        Lancet. 2017; 390: 1211-1259
        • Steiner T.J.
        • Stovner L.J.
        • Vos T.
        • et al.
        Migraine is first cause of disability in under 50s: will health politicians now take notice?.
        J Headache Pain. 2018; https://doi.org/10.1186/s10194-018-0846-2
        • Allain-Regnault M.
        • Bwibo N.O.
        • Chigier E.
        Young people’s health - A challenge for society.
        World Heal Organ - Tech Rep Ser. 1986; 731: 1-117
        • Hershey A.D.
        • Powers S.W.
        • Vockell A.L.B.
        • et al.
        Development of a patient-based grading scale for PedMIDAS.
        Cephalalgia. 2004; 24: 844-849
        • Yamani N.
        • Olesen J.
        New daily persistent headache: A systematic review on an enigmatic disorder.
        J Headache Pain. 2019; https://doi.org/10.1186/s10194-019-1022-z
        • Rozen T.D.
        New daily persistent headache (NDPH) triggered by a single Valsalva event: A case series.
        Cephalalgia. 2019; 39: 785-791
        • Grengs L.R.
        • Mack K.J.
        New Daily Persistent Headache Is Most Likely to Begin at the Start of School.
        J Child Neurol. 2016; 31: 864-868
        • Strong E.
        • Pierce E.L.
        • Langdon R.
        • et al.
        New Daily Persistent Headache in a Pediatric Population.
        J Child Neurol. 2021; 36: 888-893
        • Ghosh A.
        • Silva E.
        • Burish M.J.
        Pediatric-onset trigeminal autonomic cephalalgias: A systematic review and meta-analysis.
        Cephalalgia. 2021; 41: 1382-1395
        • Oskoui M.
        • Pringsheim T.
        • Holler-Managan Y.
        • et al.
        Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.
        Neurology. 2019; 93: 487-499
        • Patniyot I.
        • Qubty W.
        Short-term treatment of Migraine in Children and Adolescents.
        JAMA. 2020; 174: 789-790
        • Hämäläinen M.L.
        • Hoppu K.
        • Valkeila E.
        • et al.
        Ibuprofen or acetaminophen for the acute treatment of migraine in children: A double-blind, randomized, placebo-controlled, crossover study.
        Neurology. 1997; 48: 103-107
        • Lipton R.B.
        • Munjal S.
        • Brand-Schieber E.
        • et al.
        Efficacy, Tolerability, and Safety of DFN-15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study.
        Headache. 2020; 60: 58-70
        • Cady R.
        • Nett R.
        • Dexter K.
        • et al.
        Treatment of chronic migraine: A 3-month comparator study of naproxen sodium vs SumaRT/Nap.
        Headache. 2014; 54: 80-93
        • Ferrari M.D.
        • Roon K.I.
        • Lipton R.B.
        • et al.
        Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: A meta-analysis of 53 trials.
        Lancet. 2001; 358: 1668-1675
        • Kabbouche M.A.
        • Vockell A.L.
        • LeCates S.L.
        • et al.
        Tolerability and effectiveness of prochlorperazine for intractable migraine in children.
        Pediatrics. 2001; 107https://doi.org/10.1542/peds.107.4.e62
        • Trottier E.D.
        • Bailey B.
        • Lucas N.
        • et al.
        Prochlorperazine in children with migraine: A look at its effectiveness and rate of akathisia.
        Am J Emerg Med. 2012; 30: 456-463
        • Brousseau D.C.
        • Duffy S.J.
        • Anderson A.C.
        • et al.
        Treatment of Pediatric Migraine Headaches: A Randomized, Double-Blind Trial of Prochlorperazine Versus Ketorolac.
        Ann Emerg Med. 2004; 43: 256-262
        • Trottier E.D.
        • Bailey B.
        • Dauphin-Pierre S.
        • et al.
        Clinical outcomes of children treated with intravenous prochlorperazine for migraine in a pediatric emergency department.
        J Emerg Med. 2010; 39: 166-173
        • Kanis J.M.
        • Timm N.L.
        Chlorpromazine for the treatment of migraine in a pediatric emergency department.
        Headache. 2014; 54: 335-342
        • Hodgson S.E.
        • Harding A.M.
        • Bourke E.M.
        • et al.
        A prospective, randomized, double-blind trial of intravenous chlorpromazine versus intravenous prochlorperazine for the treatment of acute migraine in adults presenting to the emergency department.
        Headache. 2021; 61: 603-611
        • Marmura M.J.
        • Silberstein S.D.
        • Schwedt T.J.
        The acute treatment of migraine in adults: The american headache society evidence assessment of migraine pharmacotherapies.
        Headache. 2015; 55: 3-20
        • Jones J.
        • Pack S.
        • Chun E.
        Intramuscular prochlorperazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache.
        Am J Emerg Med. 1996; 14: 262-264
        • Friedman B.W.
        • Esses D.
        • Solorzano C.
        • et al.
        A Randomized Controlled Trial of Prochlorperazine Versus Metoclopramide for Treatment of Acute Migraine.
        Ann Emerg Med. 2008; 52: 399-406
        • Goadsby P.J.
        • Wietecha L.A.
        • Dennehy E.B.
        • et al.
        Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine.
        Brain. 2019; 142: 1894-1904
        • Croop R.
        • Goadsby P.J.
        • Stock D.A.
        • et al.
        Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial.
        Lancet. 2019; 394: 737-745
        • Dodick D.W.
        • Lipton R.B.
        • Ailani J.
        • et al.
        Ubrogepant for the Treatment of Migraine.
        N Engl J Med. 2019; 381: 2230-2241
        • Paruthi S.
        • Brooks L.J.
        • D’Ambrosio C.
        • et al.
        Consensus Statement of the American Academy of Sleep Medicine on the Recommended Amount of Sleep for Healthy Children: Methodology and Discussion.
        J Clin Sleep Med. 2016; 12: 1549-1561
        • Carskadon M.A.
        • Tarokh L.
        Developmental changes in sleep biology and potential effects on adolescent behavior and caffeine use.
        Nutr Rev. 2014; 72: 60-64
        • Hysing M.
        • Pallesen S.
        • Stormark K.M.
        • et al.
        Sleep and use of electronic devices in adolescence: Results from a large population-based study.
        BMJ Open. 2015; 5: 1-7
        • Cajochen C.
        • Frey S.
        • Anders D.
        • et al.
        Evening exposure to a light-emitting diodes (LED)-backlit computer screen affects circadian physiology and cognitive performance.
        J Appl Physiol. 2011; 110: 1432-1438
        • Howatson G.
        • Bell P.G.
        • Tallent J.
        • et al.
        Effect of tart cherry juice (Prunus cerasus) on melatonin levels and enhanced sleep quality.
        Eur J Nutr. 2012; 51: 909-916
        • Bektaş Ö.
        • Uʇur C.
        • Gençtürk Z.B.
        • et al.
        Relationship of childhood headaches with preferences in leisure time activities, depression, anxiety and eating habits: A population-based, cross-sectional study.
        Cephalalgia. 2015; 35: 527-537
        • Peris F.
        • Donoghue S.
        • Torres F.
        • et al.
        Towards improved migraine management: Determining potential trigger factors in individual patients.
        Cephalalgia. 2017; 37: 452-463
        • Gelfand Amy A.
        • Pavitt Sara
        • Greene Kaitlin
        • et al.
        High School Start Time and Migraine Frequency in High School Students.
        Headache. 2019; 59: 1024-1031
        • Goadsby P.J.
        • Holland P.R.
        • Martins-Oliveira M.
        • et al.
        Pathophysiology of Migraine: A Disorder of Sensory Processing.
        Physiol Rev. 2017; 97: 553-622
        • Cuvellier J.C.
        • Mars A.
        • Vallée L.
        The prevalence of premonitory symptoms in paediatric migraine: A questionnaire study in 103 children and adolescents.
        Cephalalgia. 2009; 29: 1197-1201
        • Karsan N.
        • Bose P.
        • Goadsby P.J.
        The Migraine Premonitory Phase.
        Contin Lifelong Learn Neurol. 2018; 24: 996-1008
        • Arca K.N.
        • Halker Singh R.B.
        Dehydration and Headache.
        Curr Pain Headache Rep. 2021; 25: 4-9
        • Perry B.G.
        • Bear T.L.K.
        • Lucas S.J.E.
        • et al.
        Mild dehydration modifies the cerebrovascular response to the cold pressor test.
        Exp Physiol. 2016; 101: 135-142
        • Kenney E.L.
        • Long M.W.
        • Cradock A.L.
        • et al.
        Prevalence of inadequate hydration among US children and disparities by gender and race/ethnicity: National Health and Nutrition Examination Survey, 2009-2012.
        Am J Public Health. 2015; 105: e113-e118
        • Spigt M.
        • Weerkamp N.
        • Troost J.
        • et al.
        A randomized trial on the effects of regular water intake in patients with recurrent headaches.
        Fam Pract. 2012; 29: 370-375
        • Khorsha F.
        • Mirzababaei A.
        • Togha M.
        • et al.
        Association of drinking water and migraine headache severity.
        J Clin Neurosci. 2020; 77: 81-84
      1. Medicine I of. Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate.; 2005. doi:10.17226/10925.

        • Amin F.M.
        • Aristeidou S.
        • Baraldi C.
        • et al.
        The association between migraine and physical exercise.
        J Headache Pain. 2018; 19: 83
        • Robberstad L.
        • Dyb G.
        • Hagen K.
        • et al.
        An unfavorable lifestyle and recurrent headaches among adolescents: The HUNT Study.
        Neurology. 2010; 75: 712-717
        • Bigal M.E.
        • Liberman J.N.
        • Lipton R.B.
        Obesity and migraine: A population study.
        Neurology. 2006; 66: 545-550
        • Varkey E.
        • Cider Å.
        • Carlsson J.
        • et al.
        Exercise as migraine prophylaxis: A randomized study using relaxation and topiramate as controls.
        Cephalalgia. 2011; 31: 1428-1438
        • Santiago M.D.S.
        • Carvalho D. de S.
        • Gabbai A.A.
        • et al.
        Amitriptyline and aerobic exercise or amitriptyline alone in the treatment of chronic migraine: A randomized comparative study.
        Arq Neuropsiquiatr. 2014; 72: 851-855
        • Oskoui M.
        • Pringsheim T.
        • Billinghurst L.
        • et al.
        Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention.
        Neurology. 2019; https://doi.org/10.1212/wnl.0000000000008105
        • Powers S.W.
        • Coffey C.S.
        • Chamberlin L.A.
        • et al.
        Trial of amitriptyline, topiramate, and placebo for pediatric migraine.
        N Engl J Med. 2017; https://doi.org/10.1056/NEJMoa1610384
        • Das R.
        • Qubty W.
        Retrospective Observational Study on Riboflavin Prophylaxis in Child and Adolescent Migraine.
        Pediatr Neurol. 2021; 114https://doi.org/10.1016/j.pediatrneurol.2020.09.009
        • Ebrahimi-Monfared M.
        • Sharafkhah M.
        • Abdolrazaghnejad A.
        • et al.
        Use of melatonin versus valproic acid in prophylaxis of migraine patients: A double-blind randomized clinical trial.
        Restor Neurol Neurosci. 2017; 35: 385-393
        • Gonçalves A.L.
        • Ferreira A.M.
        • Ribeiro R.T.
        • et al.
        Research paper: Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention.
        J Neurol Neurosurg Psychiatry. 2016; 87: 1127
        • Sazali S.
        • Badrin S.
        • Norhayati M.N.
        • et al.
        Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine-a meta-analysis.
        BMJ Open. 2021; 11https://doi.org/10.1136/BMJOPEN-2020-039358
        • von Luckner A.
        • Riederer F.
        Magnesium in Migraine Prophylaxis—Is There an Evidence-Based Rationale? A Systematic Review.
        Headache J Head Face Pain. 2018; 58: 199-209
        • Szperka C.L.
        • VanderPluym J.
        • Orr S.L.
        • et al.
        Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents.
        Headache. 2018; 58https://doi.org/10.1111/head.13414
        • Greene K.A.
        • Gentile C.P.
        • Szperka C.L.
        • et al.
        CGRP Monoclonal Antibody use for the Preventive Treatment of Refractory Headache Disorders in Adolescents.
        Pediatr Neurol. 2021; 114: 62
        • Hershey A.D.
        • Lin T.
        • Gruper Y.
        • et al.
        Remote electrical neuromodulation for acute treatment of migraine in adolescents.
        Headache. 2021; 61: 310-317
        • Chou D.E.
        • Shnayderman Yugrakh M.
        • Winegarner D.
        • et al.
        Acute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial.
        Cephalalgia. 2019; 39: 3-14
        • Grazzi L.
        • Egeo G.
        • Liebler E.
        • et al.
        No Title.
        Neurol Sci. 2017; 38: S197-S199
        • Irwin S.L.
        • Qubty W.
        • Allen I.E.
        • et al.
        Transcranial Magnetic Stimulation for Migraine Prevention in Adolescents: A Pilot Open-Label Study.
        Headache. 2018; 58: 724-731
        • Yarnitsky D.
        • Volokh L.
        • Ironi A.
        • et al.
        Nonpainful remote electrical stimulation alleviates episodic migraine pain.
        Neurology. 2017; 88: 1250-1255
        • Ailani J.
        • Burch R.C.
        • Robbins M.S.
        The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice.
        Headache. 2021; 61: 1021-1039
        • Ernst M.M.
        • O’Brien H.L.
        • Powers S.W.
        Cognitive-behavioral therapy: How medical providers can increase patient and family openness and access to evidence-based multimodal therapy for pediatric migraine.
        Headache. 2015; 55: 1382-1396
        • Power S.W.
        • Kashikar-Zuck S.M.
        • Allen J.R.
        • et al.
        Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: A randomized clinical trial.
        JAMA. 2013; 310: 2622-2630
        • Kroner J.W.
        • Hershey A.D.
        • Kashikar-Zuck S.M.
        • et al.
        Cognitive Behavioral Therapy plus Amitriptyline for Children and Adolescents with Chronic Migraine Reduces Headache Days to ≤4 per Month.
        Headache. 2016; 56: 711-716
        • Stubberud A.
        • Tronvik E.
        • Olsen A.
        • et al.
        Biofeedback Treatment App for Pediatric Migraine: Development and Usability Study.
        Headache. 2020; 60: 889-901
        • Minen M.T.
        • Adhikari S.
        • Padikkala J.
        • et al.
        Smartphone-Delivered Progressive Muscle Relaxation for the Treatment of Migraine in Primary Care: A Randomized Controlled Trial.
        Headache. 2020; 60: 2232-2246
        • Szperka C.L.
        • Gelfand A.A.
        • Hershey A.D.
        Patterns of Use of Peripheral Nerve Blocks and Trigger Point Injections for Pediatric Headache: Results of a Survey of the American Headache Society Pediatric and Adolescent Section.
        Headache. 2016; 56: 1597-1607
        • Gelfand A.A.
        • Reider A.C.
        • Goadsby P.J.
        Outcomes of greater occipital nerve injections in pediatric patients with chronic primary headache disorders.
        Pediatr Neurol. 2014; 50: 135-139
        • Robbins M.S.
        • Robertson C.E.
        • Kaplan E.
        • et al.
        The Sphenopalatine Ganglion: Anatomy, Pathophysiology, and Therapeutic Targeting in Headache.
        Headache. 2016; 56: 240-258
        • Cady R.
        • Saper J.
        • Dexter K.
        • et al.
        A double-blind, placebo-controlled study of repetitive transnasal sphenopalatine ganglion blockade with Tx360® as acute treatment for chronic migraine.
        Headache. 2015; 55: 101-116
        • Binfalah M.
        • Alghawi E.
        • Shosha E.
        • et al.
        Sphenopalatine Ganglion Block for the Treatment of Acute Migraine Headache.
        Pain Res Treat. 2018; 2018https://doi.org/10.1155/2018/2516953
        • Mousa M.A.
        • Aria D.J.
        • Mousa A.A.
        • et al.
        Sphenopalatine ganglion nerve block for the treatment of migraine headaches in the pediatric population.
        Pain Physician. 2021; 24: E111-E116
        • Kouri M.
        • Somaini M.
        • Cárdenas V.H.G.
        • et al.
        Transnasal sphenopalatine ganglion block for the preventive treatment of chronic daily headache in adolescents.
        Children. 2021; 8: 1-8
        • Marcelo R.
        • Freund B.
        The Efficacy of Botulinum Toxin in Pediatric Chronic Migraine: A Literature Review.
        J Child Neurol. 2020; 35: 844-851
        • Goenka A.
        • Yu S.G.
        • George M.
        • et al.
        Is Botox right for me: When to assess the efficacy of the Botox injection for chronic migraine in pediatric population.
        Neuropediatrics. 2022; https://doi.org/10.1055/A-1832-9168
        • Ali S.S.
        • Bragin I.
        • Rende E.
        • et al.
        Further Evidence that Onabotulinum Toxin is a Viable Treatment Option for Pediatric Chronic Migraine Patients.
        Cureus. 2019; 11https://doi.org/10.7759/CUREUS.4343
        • Shah S.
        • Calderon M.D.
        • Crain N.
        • et al.
        Effectiveness of onabotulinumtoxinA (BOTOX) in pediatric patients experiencing migraines: a randomized, double-blinded, placebo-controlled crossover study in the pediatric pain population.
        Reg Anesth Pain Med. 2021; 46: 41-48
        • Goenka A.
        • Grace Yu S.
        • Chikkannaiah M.
        • et al.
        Generalized Anxiety Disorder: A Predictor for Poor Responsiveness to Botulinum Toxin Type A Therapy for Pediatric Migraine.
        Pediatr Neurol. 2022; 130: 21-27